APA

Antonijoan R., García-Gea C., Puntes M., Pérez J., Esbrí R., Serra C., Fortea J. & Barbanoj M. J. (20070905). Comparison of inhibition of cutaneous histamine reaction of ebastine fast-dissolving tablet (20 mg) versus desloratadine capsule (5 mg): a randomized, double-blind, double-dummy, placebo-controlled, three-period crossover study in healthy, nonatopic adults. : Clinical therapeutics.

Chicago

Antonijoan Rosa, García-Gea Consuelo, Puntes Montserrat, Pérez Joselin, Esbrí Ramón, Serra Cristina, Fortea Josep and Barbanoj Manuel J. 20070905. Comparison of inhibition of cutaneous histamine reaction of ebastine fast-dissolving tablet (20 mg) versus desloratadine capsule (5 mg): a randomized, double-blind, double-dummy, placebo-controlled, three-period crossover study in healthy, nonatopic adults. : Clinical therapeutics.

Harvard

Antonijoan R., García-Gea C., Puntes M., Pérez J., Esbrí R., Serra C., Fortea J. and Barbanoj M. J. (20070905). Comparison of inhibition of cutaneous histamine reaction of ebastine fast-dissolving tablet (20 mg) versus desloratadine capsule (5 mg): a randomized, double-blind, double-dummy, placebo-controlled, three-period crossover study in healthy, nonatopic adults. : Clinical therapeutics.

MLA

Antonijoan Rosa, García-Gea Consuelo, Puntes Montserrat, Pérez Joselin, Esbrí Ramón, Serra Cristina, Fortea Josep and Barbanoj Manuel J. Comparison of inhibition of cutaneous histamine reaction of ebastine fast-dissolving tablet (20 mg) versus desloratadine capsule (5 mg): a randomized, double-blind, double-dummy, placebo-controlled, three-period crossover study in healthy, nonatopic adults. : Clinical therapeutics. 20070905.